Detalles de la búsqueda
1.
Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver.
Int J Mol Sci
; 19(8)2018 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30060508
2.
Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn's Disease: Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies.
J Crohns Colitis
; 18(1): 134-143, 2024 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37437094
3.
Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome.
Eur J Immunol
; 41(4): 1120-31, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21400500
4.
Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activity.
Radiology
; 262(2): 680-8, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22157203
5.
Ileal Crohn's disease: CEUS determination of activity.
Abdom Imaging
; 37(3): 359-68, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22223202
6.
[Predictors of clinical response in patients with ulcerative colitis treated with granulocyte-monocyte apheresis: analysis of the apheresis registry data]. / Predittori di risposta clinica in pazienti affetti da colite ulcerosa trattati con granulocito-monocito aferesi: analisi dei dati del registro aferesi.
G Ital Nefrol
; 29 Suppl 54: S144-6, 2012.
Artículo
en Italiano
| MEDLINE | ID: mdl-22388848
7.
Glucagon-like peptide-2 analogues for Crohn's disease patients with short bowel syndrome and intestinal failure.
World J Gastroenterol
; 28(44): 6258-6270, 2022 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36504557
8.
Incident Colorectal Cancer in Inflammatory Bowel Disease.
Cancers (Basel)
; 14(3)2022 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158989
9.
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy.
Expert Opin Biol Ther
; 22(2): 313-320, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34904510
10.
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease.
Clin Gastroenterol Hepatol
; 9(1): 30-5, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20951835
11.
Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience.
Int J Colorectal Dis
; 26(11): 1435-44, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21594668
12.
Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases.
J Clin Med
; 10(4)2021 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33669579
13.
Transition of inflammatory bowel disease patients from pediatric to adult care: an observational study on a joint-visits approach.
Ital J Pediatr
; 47(1): 18, 2021 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33509223
14.
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches.
Therap Adv Gastroenterol
; 14: 17562848211006669, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33995579
15.
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients.
Aliment Pharmacol Ther
; 53(2): 273-280, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33210332
16.
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients.
Expert Opin Biol Ther
; 21(1): 97-104, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33074723
17.
Magnesium Absorption in Intestinal Cells: Evidence of Cross-Talk between EGF and TRPM6 and Novel Implications for Cetuximab Therapy.
Nutrients
; 12(11)2020 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33114586
18.
TRPM7 is overexpressed in human IBD-related and sporadic colorectal cancer and correlates with tumor grade.
Dig Liver Dis
; 52(10): 1188-1194, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32505565
19.
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease.
J Crohns Colitis
; 2020 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32674156
20.
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre.
United European Gastroenterol J
; 8(7): 775-781, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32438878